BioCentury | Jul 9, 2020
Product Development
CSL testing coagulation factor blocker in COVID-19 patients; plus vaccine deals and plasma trials
...GS-5734)
CSL Ltd.
Coalition for Epidemic Preparedness Innovations (CEPI)
Sichuan Clover Biopharmaceuticals Inc.
GlaxoSmithKline plc
Dynavax Technologies Corp.
Medicago Inc.
Emergent BioSolutions Inc.
Mount Sinai Hospital
U.S...